Combined use of regorafenib with SBRT in pulmonary metastasis from colorectal cancer

Yasemin Cihan


In conclusion, metastases from colorectal cancers, particularly pulmonary metastasis,is important for determining treatment approach. In this group of patients, local ablativeapproaches (such as SBRT) are widely used in addition to systemic therapies. Today, SBRTto metastases is planned to prolong disease-free survival or to achieve cure as reportedpreviously. It seems that targeted agents such as regorafenib combined with SBRT mayprovide higher clinical benefit in these patients. Thus, it is of important to identify patient thatmay benefit from these therapies.

Klíčová slova

regorafenib, SBRT, pulmonary metastasis, colorectal cancer

Full Text:

PDF (English)

Na tento článek odkazuje

  • Aktuálně neexistují žádné citace.